Otonomy Raises $10 Million

Otonomy Inc., a San Diego-based drug company focused on disorders of the inner and middle ear, has raised $10 million in Series A funding from Avalon Ventures.

11 June 2010•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail